AIDS

1. CANIGLIA EC, Zash R, Diseko M, Mabuta J, et al
   Target trials of pre-conception switch from Nevirapine- or Efavirenz-based ART to dolutegravir-based ART on adverse birth and maternal outcomes.
   AIDS. 2025 Aug 13. doi: 10.1097/QAD.0000000000004321.
   

   >> Share

   
   
2. CALCAGNO A, Carola L, Barbara R, Marco M, et al
   Full reservoirs and poor adherence: two cases of symptomatic HIV cerebrospinal fluid escape with tenofovir alafenamide/emtricitabine/bictegravir.
   AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004320.
   

   >> Share

   
   

   
   Clin Infect Dis

3. NUTT CT, Lessells RJ, Muyindike WR, Johnson LS, et al
   Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries with the Highest Adult HIV Prevalence.
   Clin Infect Dis. 2025 Aug 11:ciaf444. doi: 10.1093.
   

   >> Share

   
   

   
   J Acquir Immune Defic Syndr

4. D'ANTONI ML, Andreatta K, Chang S, Cox S, et al
   Brief Report: HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of ALLIANCE Data
   J Acquir Immune Defic Syndr. 2024;96:380-384.
   

   >> Share

   
   

   
   J Virol

5. KARIMI A, Lieber CM, Sakamoto K, Plemper RK, et al
   SARS-CoV-2 causes chronic lung inflammation and impaired respiratory capacity in aged Roborovski dwarf hamsters.
   J Virol. 2025 Aug 11:e0075525. doi: 10.1128/jvi.00755.
   

   >> Share

   
   

   
   PLoS One

6. MUCHINTA E, Chabala FW
   Chronic kidney disease among HIV-positive Zambian adults with tenofovir-associated nephrotoxicity at University Teaching Hospital (UTH) in Lusaka.
   PLoS One. 2025;20:e0330356.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share